Frederick C. Beddingfield III
2018
In 2018, Frederick C. Beddingfield III earned a total compensation of $2.6M as President and Chief Executive Officer at Sienna Biopharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $254,000 |
|---|---|
| Option Awards | $1,854,799 |
| Salary | $508,000 |
| Total | $2,616,799 |
Beddingfield received $1.9M in option awards, accounting for 71% of the total pay in 2018.
Beddingfield also received $254K in non-equity incentive plan and $508K in salary.
Rankings
In 2018, Frederick C. Beddingfield III's compensation ranked 4,462nd out of 14,244 executives tracked by ExecPay. In other words, Beddingfield earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,462 out of 14,244 | 69th |
Division Manufacturing | 1,670 out of 5,762 | 71st |
Major group Chemicals And Allied Products | 600 out of 2,125 | 72nd |
Industry group Drugs | 501 out of 1,814 | 72nd |
Industry Pharmaceutical Preparations | 390 out of 1,388 | 72nd |
Source: SEC filing on April 11, 2019.
Beddingfield's colleagues
We found two more compensation records of executives who worked with Frederick C. Beddingfield III at Sienna Biopharmaceuticals in 2018.